French private equity manager Ardian has entered into an exclusive arrangement to buy Envision Pharma from US-based private equity firm the Halifax Group in a deal said to be worth between £200 million and £250 million, according to people familiar with the matter.
The agreement comes following a highly competitive auction process involving private equity firms including Advent International, Bridgepoint and Vitruvian Partners, said the same people.
